Article Type
Article
Changed
Tue, 10/03/2023 - 14:35
Display Headline
Data Trends 2023: PTSD and Psychedelic Treatments

Click to view more from Federal Health Care Data Trends 2023.

References

15. US Department of Veterans Affairs. How common is PTSD in veterans? Updated February 3, 2023. Accessed April 21, 2023. https://www.ptsd.va.gov/understand/common/common_veterans.asp
16. Murphy D, Smith KV. J Trauma Stress. 2018;31(5):753-763. doi:10.1002/jts.22333
17. Gray JC et al. Mil Med. 2022;usac400. doi:10.1093/milmed/usac400
18. Herrington AJ. VA studying psychedelics as mental health treatment for veterans. Forbes. Published June 24, 2022. Accessed April 21, 2023. https://www.forbes.com/sites/ajherrington/2022/06/24/va-studying-psychedelics-as-mental-health-treatment-for-veterans/?sh=149266f6c0d4
19. Search of: Veterans: Ketamine - list results. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/results?cond=ketamine&term=veterans&cntry=&state=&city=&dist=. Accessed March 23, 2023.
20. Mithoefer MC et al. Lancet Psychiatry. 2018;5(6):486-497. doi:10.1016/S2215-0366(18)30135-4
21. Mitchell JM et al. Nat Med. 2021;27(6):1025-1033. doi:10.1038/s41591-021-01336-3
22. Abdallah CG et al. Neuropsychopharmacology. 2022;47(8):1574-1581. doi:10.1038/s41386-022-01266-9
23. Artin H et al. EClinicalMedicine. 2022;48:101439. doi:10.1016/j.eclinm.2022.101439

Publications
Federal Practitioner
Topics
Mental Health
PTSD

Click to view more from Federal Health Care Data Trends 2023.

Click to view more from Federal Health Care Data Trends 2023.

References

15. US Department of Veterans Affairs. How common is PTSD in veterans? Updated February 3, 2023. Accessed April 21, 2023. https://www.ptsd.va.gov/understand/common/common_veterans.asp
16. Murphy D, Smith KV. J Trauma Stress. 2018;31(5):753-763. doi:10.1002/jts.22333
17. Gray JC et al. Mil Med. 2022;usac400. doi:10.1093/milmed/usac400
18. Herrington AJ. VA studying psychedelics as mental health treatment for veterans. Forbes. Published June 24, 2022. Accessed April 21, 2023. https://www.forbes.com/sites/ajherrington/2022/06/24/va-studying-psychedelics-as-mental-health-treatment-for-veterans/?sh=149266f6c0d4
19. Search of: Veterans: Ketamine - list results. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/results?cond=ketamine&term=veterans&cntry=&state=&city=&dist=. Accessed March 23, 2023.
20. Mithoefer MC et al. Lancet Psychiatry. 2018;5(6):486-497. doi:10.1016/S2215-0366(18)30135-4
21. Mitchell JM et al. Nat Med. 2021;27(6):1025-1033. doi:10.1038/s41591-021-01336-3
22. Abdallah CG et al. Neuropsychopharmacology. 2022;47(8):1574-1581. doi:10.1038/s41386-022-01266-9
23. Artin H et al. EClinicalMedicine. 2022;48:101439. doi:10.1016/j.eclinm.2022.101439

References

15. US Department of Veterans Affairs. How common is PTSD in veterans? Updated February 3, 2023. Accessed April 21, 2023. https://www.ptsd.va.gov/understand/common/common_veterans.asp
16. Murphy D, Smith KV. J Trauma Stress. 2018;31(5):753-763. doi:10.1002/jts.22333
17. Gray JC et al. Mil Med. 2022;usac400. doi:10.1093/milmed/usac400
18. Herrington AJ. VA studying psychedelics as mental health treatment for veterans. Forbes. Published June 24, 2022. Accessed April 21, 2023. https://www.forbes.com/sites/ajherrington/2022/06/24/va-studying-psychedelics-as-mental-health-treatment-for-veterans/?sh=149266f6c0d4
19. Search of: Veterans: Ketamine - list results. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/results?cond=ketamine&term=veterans&cntry=&state=&city=&dist=. Accessed March 23, 2023.
20. Mithoefer MC et al. Lancet Psychiatry. 2018;5(6):486-497. doi:10.1016/S2215-0366(18)30135-4
21. Mitchell JM et al. Nat Med. 2021;27(6):1025-1033. doi:10.1038/s41591-021-01336-3
22. Abdallah CG et al. Neuropsychopharmacology. 2022;47(8):1574-1581. doi:10.1038/s41386-022-01266-9
23. Artin H et al. EClinicalMedicine. 2022;48:101439. doi:10.1016/j.eclinm.2022.101439

Publications
Federal Practitioner
Publications
Federal Practitioner
Topics
Mental Health
PTSD
Article Type
Article
Display Headline
Data Trends 2023: PTSD and Psychedelic Treatments
Display Headline
Data Trends 2023: PTSD and Psychedelic Treatments
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Eyebrow Default
Slideshow
Gate On Date
Thu, 09/21/2023 - 10:00
Un-Gate On Date
Thu, 09/21/2023 - 10:00
Use ProPublica
CFC Schedule Remove Status
Thu, 09/21/2023 - 10:00
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Article Slideshow Optional Introduction

Slideshow below.

Veterans experience a higher lifetime prevalence of PTSD and poorer treatment responses compared with civilians.15,16 Current research is focused on novel treatments, such as psychedelic psychotherapy. Despite some lingering concerns, veterans have reported that they support psychedelic psychotherapy in medical settings if proven beneficial.17 Several VA locations are conducting clinical trials for this novel research, such as the Bronx VA and San Diego VA, among others.18,19 The psychedelic agent that has shown the most promise thus far is 3,4-methylenedioxymethamphetamine (MDMA). In veterans, MDMA has been shown to lower Clinician-Administered PTSD Scale (CAPS) scores by as much as 58.3 points, and is more effective than placebo.20,21 As more psychedelics continue to be explored,22,23 future use of psychedelic psychotherapy could be a gamechanger for the PTSD treatment landscape, so long as current legal barriers are overcome.

Slide
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article
Slide Media